JAAD Ethics Review Targets Coordinated Interview Releases

The Journal of the American Academy of Dermatology will publish a five-author ethics commentary, "First come, first served: Ethics of coordinated interview releases," in its November 2026 issue (Volume 95, Issue 5). The byline lists Gustavo Freitas, Lauren Fleshner, Timothy Klufas, Albert E. Zhou, and Jane M. Grant-Kels.

What is a coordinated interview release?

A coordinated interview release — usually branded an "embargoed exclusive" — gives one source to multiple reporters under a single rule: no outlet publishes before a set date and time.

The format has become standard for pharmaceutical launches, dermatology device rollouts, and society guideline announcements. Reporters get early access. Sources control the rollout.

Readers see nearly identical Q&As appear across competing outlets at the same minute, often within seconds of each other. The arrangement benefits everyone on paper. Reporters land a "scoop" that isn't really a scoop. Sources get blanket coverage without picking favorites. Readers get volume.

The arrangement also blurs lines. Which outlet actually broke the story? Which reporter earned the byline? And, more pointedly, who paid for the press event that produced the quote?

Coordinated releases have grown common in dermatology over the last decade as new biologics, fillers, energy-based devices, and skin-cancer screening campaigns have crowded the launch calendar. Each launch invites the same choreography: a press kit, a quote sheet, three to five reporters on a single call, and a synchronized publish moment.

Why is JAAD running it?

The Journal of the American Academy of Dermatology, the field's highest-impact clinical title, routinely uses its editorial pages to revisit the overlap between medical communication and conflict-of-interest reporting. Coordinated releases sit exactly on that overlap.

A JAAD commentary on the practice reaches dermatologists who serve as quoted experts — a role that already carries formal disclosure obligations.

The five-author roster signals a working-group product, not a single voice. Coordinated editorial bylines in JAAD typically mean a panel has drafted, reviewed, and signed off on a position — closer to a society white paper than a lone op-ed.

What does this change for clinicians?

For most practicing dermatologists, nothing immediate. The article is an editorial, not a clinical guideline.

For department chairs, society spokespeople, and the KOLs who field reporter calls each quarter, the commentary serves as a reminder: coordinated releases don't replace disclosure obligations, they overlap with them.

A quoted expert who appears in three coordinated interviews on the same device launch has, in effect, made three endorsements, not one. That's a small distinction with a large audit-trail implication.

Compliance officers who log physician media appearances can now log a cluster as one event or as several. The article's title alone — "first come, first served" — signals which way the authors lean.

What's next to watch

The November 2026 JAAD issue lands at the start of the late-fall dermatology meeting circuit, where society press officers gather. Watch those press officers.

Their internal guidance tends to shift within weeks of any JAAD editorial on media practice, and a coordinated-release piece is exactly the kind of commentary that prompts a memo.

Two months after publication, the better question is whether any of the field's largest dermatology societies — AAD, the cosmetic and surgical specialty societies — revise their media-coaching scripts for physician spokespeople. The downstream question is whether reporters, in turn, begin flagging coordinated releases in their bylines or story tags.

The footnote list will travel further than the commentary itself.